Title
Cohort profile: The study of respiratory pathogens in Andean children
Date Issued
01 January 2014
Access level
open access
Resource Type
journal article
Publisher(s)
Oxford University Press
Abstract
We investigated respiratory pathogens in a prospective cohort study of young children living in the Peruvian Andes. In the study we assessed viral respiratory infections among young children, and explored interactions of viruses with common respiratory bacteria, especially Streptococcus pneumoniae. Through weekly household visits, data were collected on the signs and symptoms of acute respiratory illness (ARI), nasal samples were collected to test for viruses during episodes of ARI, and nasopharyngeal samples were collected on a monthly basis to monitor bacterial colonisation. We also collected data on vaccination coverage, patterns of social mixing, geographic information, and environmental and socio-demographic variables. Understanding the interaction of respiratory viruses with bacteria and its impact on the burden and severity of ARIs in rural areas of developing countries is critical to designing strategies for preventing such infections. Investigators interested in more details about this study or in accessing these resources should contact Dr. Carlos G. Grijalva at Vanderbilt University (carlos.grijalva@vanderbilt.edu). © The Author 2013; Published by Oxford University Press on behalf of the International Epidemiological Association all rights reserved.
Start page
1021
End page
1030
Volume
43
Issue
4
Language
English
OCDE Knowledge area
Pediatría Sistema respiratorio
Scopus EID
2-s2.0-84905669595
PubMed ID
Source
International Journal of Epidemiology
ISSN of the container
0300-5771
Sponsor(s)
The study is supported in part by a Clinical and Translational Science Awards (CTSA) grant to Vanderbilt University from the US National Institutes of Health (NIH), an investigator-initiated research grant from Pfizer, and a grant from the Thrasher Research Fund. The study protocol was approved by the Vanderbilt Institutional Review Board (Nashville, TN, USA), and by the Ethics Committee of the Instituto de Investigacion Nutricional, IIN (Lima, Peru). The study was implemented in communities that participated in a community-cluster randomized trial, that evaluated an integrated home-based intervention package described below. It was conducted by the IIN and the Swiss Tropical and Public Health Institute, in Basel, Switzerland and supported by the UBS Optimus Foundation.27 port for the study from Pfizer and has served as consultant for Glaxo–Smith-Kline. J.V.W. serves on the Scientific Advisory Board of Quidel. K.P.K. has received research support from Pfizer and has provided consultancy to Pfizer and Glaxo–Smith-Kline. The present study is supported by the Vanderbilt University CTSA grant UL1 RR024975-01 from the US National Institutes of Health, an investigator-initiated research grant IIR WS1898786(0887X1-4492) from Pfizer, and a grant from the Thrasher Research Fund (grant 02832-9).
Sources of information: Directorio de Producción Científica Scopus